Ignite Creation Date:
2024-05-06 @ 3:28 PM
Last Modification Date:
2024-10-26 @ 1:50 PM
Study NCT ID:
NCT04641871
Status:
COMPLETED
Last Update Posted:
2024-06-26
First Post:
2020-10-29
Brief Title:
Sym021 in Combination With Either Sym022 or Sym023 or Sym023 and Irinotecan in Patients With Recurrent Advanced Selected Solid Tumor Malignancies
Sponsor:
Symphogen AS
Organization:
Symphogen AS
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Solid Tumor |
| Metastatic Cancer |